Yiju Wei

ORCID: 0000-0003-0962-287X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hippo pathway signaling and YAP/TAZ
  • Ferroptosis and cancer prognosis
  • RNA Research and Splicing
  • RNA modifications and cancer
  • Ubiquitin and proteasome pathways
  • Cellular Mechanics and Interactions
  • Cancer, Lipids, and Metabolism
  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Immune Response and Inflammation
  • Barrier Structure and Function Studies
  • Air Quality Monitoring and Forecasting
  • Genetic factors in colorectal cancer
  • Genetics and Neurodevelopmental Disorders
  • Wnt/β-catenin signaling in development and cancer
  • Cancer Genomics and Diagnostics
  • Cell death mechanisms and regulation
  • Neurological diseases and metabolism
  • Cancer-related gene regulation
  • Molecular Biology Techniques and Applications
  • Air Quality and Health Impacts
  • Cancer-related molecular mechanisms research
  • Cancer Research and Treatments
  • Genomics and Rare Diseases
  • Renal and related cancers

Shandong First Medical University
2023-2025

Chinese Academy of Medical Sciences & Peking Union Medical College
2014-2022

Penn State Milton S. Hershey Medical Center
2018-2021

Kaohsiung Medical University
2021

Hopp Children's Cancer Center Heidelberg
2019

Pennsylvania State University
2018

Institute of Medical Biology
2014

University of Electronic Science and Technology of China
2013

Abstract Tumor necrosis commonly exists and predicts poor prognoses in many cancers. Although it is thought to result from chronic ischemia, the underlying nature mechanisms driving involved cell death remain obscure. Here, we show that glioblastoma (GBM) involves neutrophil-triggered ferroptosis. In a hyperactivated transcriptional coactivator with PDZ-binding motif-driven GBM mouse model, neutrophils coincide temporally spatially. Neutrophil depletion dampens necrosis. Neutrophils isolated...

10.1038/s41467-020-19193-y article EN cc-by Nature Communications 2020-10-27

Abstract YAP1 fusion-positive supratentorial ependymomas predominantly occur in infants, but the molecular mechanisms of oncogenesis are unknown. Here we show YAP1-MAMLD1 fusions sufficient to drive malignant transformation mice, and resulting tumors share histo-molecular characteristics human ependymomas. Nuclear localization protein is mediated by MAMLD1 independent YAP1-Ser127 phosphorylation. Chromatin immunoprecipitation-sequencing analyses YAP1-MAMLD1-positive ependymoma reveal...

10.1038/s41467-019-11884-5 article EN cc-by Nature Communications 2019-09-02

Intratumor heterogeneity associates with cancer progression and may account for a substantial portion of therapeutic resistance. Although extensive studies have focused on the origin heterogeneity, biological interactions between heterogeneous malignant cells within tumor are largely unexplored. Glioblastoma (GBM) is most aggressive primary brain tumor. Here, we found that expression Yes-associated protein (YAP, also known as YAP1) intratumorally in GBM. In xenograft mouse model,...

10.1242/jcs.225714 article EN publisher-specific-oa Journal of Cell Science 2019-01-01

The Hippo pathway effector TAZ promotes cellular growth, survival, and stemness through regulating gene transcription. Recent studies suggest that liquid-liquid phase separation (LLPS) compartmentalizes key cofactors to activate However, how LLPS is achieved remains unknown. Here, it shown the paraspeckle protein NONO required for activation in nucleus. a TAZ-binding protein. Their interaction shows temporal regulation parallel between TEAD as well expression of target genes. depletion...

10.1002/advs.202102653 article EN Advanced Science 2021-10-29

Exposure to airborne particulate matter (PM) is a major risk which increases pulmonary diseases such as asthma, chronic bronchitis, or obstructive disease (COPD). PM complex mixture with physiochemical properties that can vary over time and space, presenting challenge when attempting analyze their health risks. In this study, we compared two kinds of commercial real explore an index takes account both the diverse physicochemical accurate prediction toxicities. Our results indicated oxidative...

10.1016/j.ecoenv.2025.117845 article EN cc-by-nc-nd Ecotoxicology and Environmental Safety 2025-02-01

The traditional vaccine adjuvant research is mainly based on the trial and error method, mechanisms underlying immune system stimulation remaining largely unknown. We previously demonstrated that heparan sulfate (HS), a TLR-4 ligand endogenous danger signal, effectively enhanced humoral cellular responses in mice immunized by HBsAg. This study aimed to evaluate whether HS induces better against inactivated Hepatitis A or Rabies Vaccines, respectively, compared with adjuvants (e.g. Alum...

10.4161/21645515.2014.980682 article EN Human Vaccines & Immunotherapeutics 2014-12-02

Background: Infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2) is a rare autosomal recessive neurodevelopmental disorder caused by mutations in the UNC80 gene. It characterized severe global developmental delay, poor or absent speech limited walking abilities. The current study explored case of Chinese patient IHPRF2 novel splicing variant . Case Report: proband 8-year-old male manifested truncal hypotonia, intellectual disability. SNP array analysis...

10.3389/fgene.2021.747422 article EN cc-by Frontiers in Genetics 2021-09-14

Pantothenate kinase-associated neurodegeneration (PKAN) is a rare genetic neurodegenerative disorder with brain iron accumulation characterized as dysarthria, spasticity, cognitive impairment, parkinsonism, and retinopathy. PKAN caused by biallelic mutations in the mitochondrial pantothenate kinase 2 ( PANK2 ) gene. Herein, we report 4-year-old patient from Han Chinese family, who presented developmental regression, progressive inability to walk, limb tremors. Neuroimaging demonstrated...

10.3389/fneur.2023.1170557 article EN cc-by Frontiers in Neurology 2023-04-28

Ependymoma (EPN) is one of the most aggressive pediatric brain tumors, often arising in supratentorial (ST) region. Our previous DNA methylation profiling study has identified ST-EPN subgroups that are characterized by YAP1-related fusions through genomic structural rearrangements (hereafter called as ST-EPN-YAP1). No reports amplification and hyper-activation YAP1 gene ST-EPN-YAP1s postulate could have unique oncogenic function(s) this type cancer. Nevertheless, lack adequate models for...

10.1093/neuonc/noz036.063 article EN Neuro-Oncology 2019-04-01

Abstract Tumor necrosis indicates poor prognoses in many cancers, including glioblastomas (GBMs). Although thought to result from chronic ischemia, the underlying nature and mechanisms driving involved cell death remain obscured by lack of animal models recapitulating extent human GBMs. The molecular clinical heterogeneity GBMs adds further complexity. Not all contain necrosis. Mesenchymal (MES)-GBM, subtype correlated with worst prognosis highest treatment resistance, is most closely...

10.1093/neuonc/noaa215.912 article EN Neuro-Oncology 2020-11-01

Programming oriented on-machine examination (POME) faces some new cheating challenges.They exploit the features of third-party programming tools used in POME.Traditional methods, such as screen taking over, packet filtering, traditional system could not prevent based on tools, so they are useless POME.To address problems POME, an API hooking hybrid mechanism is proposed.By killing processes a black list and related APIs thirdparty can effectively decrease rates POME

10.2991/icibet.2013.10 article EN cc-by-nc Proceedings of the 2013 International Conference on Information, Business and Education Technology (ICIBET 2013) 2013-01-01

Glioblastoma (GBM), the deadliest and most common primary CNS malignancy in adults, is highly heterogeneous with variable prognoses treatment responses. The molecular underpinnings for such variability remain largely unclear. Mesenchymal (MES)-GBMs, associated poorest prognosis highest resistance, exhibit hyperactivity of transcriptional coactivator PDZ-binding motif (TAZ), major effector Hippo tumor suppressive pathway. Additionally, microenvironment (TME) MES-GBMs appears to be altered,...

10.1093/neuonc/noy148.1109 article EN Neuro-Oncology 2018-11-01

Abstract Glioblastoma (GBM), the deadliest and most common adult brain malignancy, is molecularly clinically heterogeneous. The subtype (both primary recurrent), mesenchymal (MES)-GBM, has worst prognosis highest treatment resistance. MES-GBM exhibits hyperactive transcriptional coactivator with PDZ-binding motif (TAZ), a Hippo tumor suppressive pathway effector whose expression in GBMs predicts short survival. Yet, how Hippo-TAZ dysregulation might drive GBM MES transition remains elusive,...

10.1093/neuonc/noz175.1049 article EN Neuro-Oncology 2019-11-01

Abstract YAP1 fusion-positive supratentorial ependymomas predominantly occur in infants, but the molecular mechanisms of oncogenesis are unknown. Here we show YAP1-MAMLD1 fusions not wildtype sufficient to drive malignant transformation neural progenitors developing cerebral cortex mice, and resulting tumours share histo-molecular characteristics human ependymomas. Nuclear localization protein is associated with its oncogenicity mediated by nuclear signal MAMLD1 a YAP1-Ser127...

10.1093/noajnl/vdz039.048 article EN cc-by-nc Neuro-Oncology Advances 2019-12-01

Abstract Glioblastoma (GBM), the deadliest and most common primary brain malignancy in adults, is highly heterogeneous with variable prognoses treatment responses. The mesenchymal subtype of GBM associated worst prognosis highest resistance. It still not clear how differentiation achieved. Hyperactivity transcriptional coactivator PDZ-binding motif (TAZ) was linked to transformation, although its role this process remains unclear. Here, by using orthotopic xenograft mouse models, we found...

10.1158/1557-3125.hippo19-b17 article EN Molecular Cancer Research 2020-08-01
Coming Soon ...